162 related articles for article (PubMed ID: 3555440)
1. Dapsone and sulfapyridine therapy of pemphigoid diseases.
Rogers RS
Australas J Dermatol; 1986 Aug; 27(2):58-63. PubMed ID: 3555440
[No Abstract] [Full Text] [Related]
2. Dapsone as first line therapy for bullous pemphigoid.
Venning VA; Millard PR; Wojnarowska F
Br J Dermatol; 1989 Jan; 120(1):83-92. PubMed ID: 2700666
[TBL] [Abstract][Full Text] [Related]
3. Chronic bullous disease of childhood--aspects of management.
Rogers M; Bartlett B; Walder B; Cains G
Australas J Dermatol; 1982 Aug; 23(2):62-9. PubMed ID: 6758754
[No Abstract] [Full Text] [Related]
4. Bullous pemphigoid responding to sulfapyridine and the sulfones.
Person JR; Rogers RS
Arch Dermatol; 1977 May; 113(5):610-5. PubMed ID: 324403
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of cicatrical pemphigoid with DDS].
Mashkilleĭson AL; Golousenko IIu; Antonova TN
Vestn Dermatol Venerol; 1984 Oct; (10):37-9. PubMed ID: 6393631
[No Abstract] [Full Text] [Related]
6. Three blistering diseases. Why proper management is critical.
Wooldridge WE
Postgrad Med; 1990 Sep; 88(3):103-4, 106. PubMed ID: 2204894
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone.
Rogers RS; Seehafer JR; Perry HO
J Am Acad Dermatol; 1982 Feb; 6(2):215-23. PubMed ID: 7037880
[TBL] [Abstract][Full Text] [Related]
8. Dapsone for the treatment of bullous pemphigoid.
Piamphongsant T
Asian Pac J Allergy Immunol; 1983 Jun; 1(1):19-21. PubMed ID: 6398078
[No Abstract] [Full Text] [Related]
9. The management of intransigent desquamative gingivitis with Dapsone.
Matthews RW; Pinkney RC; Scully C
Ann Dent; 1989; 48(1):41-3. PubMed ID: 2675748
[TBL] [Abstract][Full Text] [Related]
10. Treatment of subepidermal immunobullous diseases.
Wojnarowska F; Kirtschig G; Khumalo N
Clin Dermatol; 2001; 19(6):768-77. PubMed ID: 11705687
[No Abstract] [Full Text] [Related]
11. Dapsone for the treatment of vesiculo-bullous and pustular diseases.
Piamphongsant T
Int J Dermatol; 1982 Nov; 21(9):512. PubMed ID: 6218127
[No Abstract] [Full Text] [Related]
12. Adjuvant therapy of bullous pemphigoid with dapsone.
Jeffes EW; Ahmed AR
Clin Exp Dermatol; 1989 Mar; 14(2):132-6. PubMed ID: 2689016
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic experience in pemphigus and pemphigoid].
Aloi FG; Pippione M
G Ital Dermatol Venereol; 1984; 119(5):357-64. PubMed ID: 6392076
[No Abstract] [Full Text] [Related]
14. Cicatricial pemphigoid (benign mucous membrane pemphigoid).
Terezhalmy GT; Bergfeld WF
Quintessence Int; 1998 Jul; 29(7):429-37. PubMed ID: 9759059
[TBL] [Abstract][Full Text] [Related]
15. Ocular cicatricial pemphigoid.
Tauber J
Ophthalmology; 2008 Sep; 115(9):1639-40; author reply 1640-1. PubMed ID: 18762085
[No Abstract] [Full Text] [Related]
16. Sulphamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid.
McFadden JP; Leonard JN; Powles AV; Rutman AJ; Fry L
Br J Dermatol; 1989 Dec; 121(6):759-62. PubMed ID: 2692691
[TBL] [Abstract][Full Text] [Related]
17. Dapsone--other indications.
Barranco VP
Int J Dermatol; 1982 Nov; 21(9):513-4. PubMed ID: 6218128
[No Abstract] [Full Text] [Related]
18. Bullous and cicatricial pemphigoid. Clinical, histopathologic, and immunopathologic correlations.
Person JR; Rogers RS
Mayo Clin Proc; 1977 Jan; 52(1):54-66. PubMed ID: 344998
[TBL] [Abstract][Full Text] [Related]
19. The course of chronic bullous disease of childhood.
Surbrugg SK; Weston WL
Pediatr Dermatol; 1985 Mar; 2(3):213-5. PubMed ID: 3887342
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes.
Saw VP; Dart JK; Rauz S; Ramsay A; Bunce C; Xing W; Maddison PG; Phillips M
Ophthalmology; 2008 Feb; 115(2):253-261.e1. PubMed ID: 17655931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
